Andrew P. Catchpole

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Controlled human influenza infection reveals heterogeneous expulsion of infectious virus into air.

Controlled human influenza infection reveals heterogeneous expulsion of infectious virus into air.

Journal: medRxiv : the preprint server for health sciences

Published: November 24, 2025

Viral dynamics of the Respiratory Syncytial Virus during experimental human challenge: insights for transmission and protection.

Viral dynamics of the Respiratory Syncytial Virus during experimental human challenge: insights for transmission and protection.

Journal: The Journal of infectious diseases

Published: November 21, 2025

Human Challenge Trial of a Nucleoside-Modified Messenger Ribonucleic Acid Influenza Vaccine.

Human Challenge Trial of a Nucleoside-Modified Messenger Ribonucleic Acid Influenza Vaccine.

Journal: NEJM evidence

Published: November 19, 2025

Correction for Shetty et al., "Influenza virus infection and aerosol shedding kinetics in a controlled human infection model".

Correction for Shetty et al., "Influenza virus infection and aerosol shedding kinetics in a controlled human infection model".

Journal: Journal of virology

Published: October 07, 2025

Feasibility and Safety of Aerosolized Influenza Virus Challenge in Humans Using Two Modern Delivery Systems.

Feasibility and Safety of Aerosolized Influenza Virus Challenge in Humans Using Two Modern Delivery Systems.

Journal: The Journal of infectious diseases

Published: August 10, 2025

Correction: A Phase 2a, Randomized, Placebo-Controlled Human Challenge Trial to Evaluate the Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated with Respiratory Syncytial Virus.

Correction: A Phase 2a, Randomized, Placebo-Controlled Human Challenge Trial to Evaluate the Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated with Respiratory Syncytial Virus.

Journal: Pulmonary therapy

Published: May 09, 2025

Pre-existing and early cellular immune factors correlate with functionally complete protection against primary controlled human SARS-CoV-2 infection.

Pre-existing and early cellular immune factors correlate with functionally complete protection against primary controlled human SARS-CoV-2 infection.

Journal: Nature communications

Published: March 24, 2025

A Phase II, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of HEX17, a Novel Broad-Spectrum Antiviral Drug, in a Controlled Human Infection Model of Influenza Challenge.

A Phase II, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of HEX17, a Novel Broad-Spectrum Antiviral Drug, in a Controlled Human Infection Model of Influenza Challenge.

Journal: Infectious diseases and therapy

Published: March 19, 2025

Controlled human influenza infection reveals heterogeneous expulsion of infectious virus into air.

Controlled human influenza infection reveals heterogeneous expulsion of infectious virus into air.

Journal: Cell

Published: January 20, 2025

A Phase 2a, Randomized, Placebo-Controlled Human Challenge Trial to Evaluate the Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated with Respiratory Syncytial Virus.

A Phase 2a, Randomized, Placebo-Controlled Human Challenge Trial to Evaluate the Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated with Respiratory Syncytial Virus.

Journal: Pulmonary therapy

Published: November 15, 2024

Author Correction: Human SARS-CoV-2 challenge uncovers local and systemic response dynamics.

Author Correction: Human SARS-CoV-2 challenge uncovers local and systemic response dynamics.

Journal: Nature

Published: August 01, 2024

Changes in memory and cognition during the SARS-CoV-2 human challenge study.

Changes in memory and cognition during the SARS-CoV-2 human challenge study.

Journal: EClinicalMedicine

Published: May 07, 2024

Showing 1-12 of 34

Last Updated: 09/26/2026